$1.951.02%-0.02
After Hours: 1.93-0.02 -1.03%
Aclarion Inc (ACON)
Date: 2026-10-30 16:00O: 2.00H: 2.00L: 1.88C: 1.95Vol: 18.13k
Aclarion Inc stock is traded at $1.95, with a volume of 18,127. It is down -1.02% in the last 24 hours and down -19.09% over the past month. Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Previous Close:
$1.97
Open:
$2.00
24h Volume:
18,127
Relative Volume:
1.34
Market Cap:
$5.62M
Revenue:
$77,900
Net Income/Loss:
-$8.05M
P/E Ratio:
-
EPS:
-$9.23
Net Cash Flow:
-$7.47M
1W Performance:
+1.04%
1M Performance:
-19.09%
6M Performance:
-41.27%
1Y Performance:
-74.77%
1-Day Range:
$1.88$2.00
1-Week Range:
$1.88$2.06
52-Week Range:
$1.85$9.36
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion IncSector
HealthcareIndustry
Health Information ServicesPhone
833 275 2266Address
8181 ARISTA PLACE, BROOMFIELD, USACompare ACON vs VEEV, BTSG, TEM, HNGE, HQY
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aclarion Inc Stock (ACON) Insider Trading
- Gould Gregory AAug 14 '26CFO
- Transaction
- Buy
- Cost
- $2.45
- #Shares
- 10,000
- Value ($)
- 24,500
- #Shares Total
- 60,000
- Bond RyanAug 13 '26Director
- Transaction
- Buy
- Cost
- $2.37
- #Shares
- 21,122
- Value ($)
- 50,059
- #Shares Total
- 76,122
- Wesemann WilliamAug 13 '26Director
- Transaction
- Buy
- Cost
- $2.34
- #Shares
- 2,150
- Value ($)
- 5,031
- #Shares Total
- 23,713
- Neal David KAug 13 '26Director
- Transaction
- Buy
- Cost
- $2.40
- #Shares
- 7,500
- Value ($)
- 18,000
- #Shares Total
- 30,002
- Ness BrentAug 13 '26Chief Executive Officer
- Transaction
- Buy
- Cost
- $2.31
- #Shares
- 5,234
- Value ($)
- 12,091
- #Shares Total
- 111,534
- Breidbart ScottMay 12 '26Director
- Transaction
- Buy
- Cost
- $3.18
- #Shares
- 5,664
- Value ($)
- 18,012
- #Shares Total
- 5,664
- Neal David KMay 11 '26Director
- Transaction
- Buy
- Cost
- $3.10
- #Shares
- 2,500
- Value ($)
- 7,750
- #Shares Total
- 2,502
- Ness BrentMay 11 '26Chief Executive Officer
- Transaction
- Buy
- Cost
- $3.18
- #Shares
- 6,289
- Value ($)
- 19,999
- #Shares Total
- 6,300
- Wesemann WilliamMay 06 '26Director
- Transaction
- Buy
- Cost
- $3.30
- #Shares
- 1,562
- Value ($)
- 5,155
- #Shares Total
- 1,563
- Ness BrentNov 26 '25Chief Executive Officer
- Transaction
- Buy
- Cost
- $6.20
- #Shares
- 10
- Value ($)
- 62
- #Shares Total
- 11